Kaiserslautern, Germany

Sabine Schiemann

This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sabine Schiemann. Retrieved from https://idiyas.com/inventor/sabine-schiemann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sabine Schiemann: Innovator in Tumor Diagnosis and Therapy

Introduction

Sabine Schiemann is a prominent inventor based in Kaiserslautern, Germany. She has made significant contributions to the field of oncology, particularly in the diagnosis and treatment of breast carcinoma. Her innovative work has led to the development of a pharmaceutical composition that plays a crucial role in tumor diagnosis, therapy, and prevention.

Latest Patents

Sabine Schiemann holds 1 patent related to a breast carcinoma-associated gene. This patent encompasses a pharmaceutical composition, methods for diagnosing, treating, and preventing tumors, as well as antibodies and their applications in oncology.

Career Highlights

Schiemann is currently associated with Roche Diagnostics GmbH, where she continues to advance her research and development efforts. Her work at Roche has positioned her as a key player in the field of diagnostic solutions for cancer.

Collaborations

One of her notable collaborators is Ulrich Weidle, with whom she has worked closely to enhance the understanding and treatment of breast cancer.

Conclusion

Sabine Schiemann's contributions to the field of tumor diagnosis and therapy highlight her role as an influential inventor. Her innovative approaches continue to impact the medical community and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…